2-(4-(tert-butyl)-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACOOUR636
CAS No. :
2243254-46-6
Molecular Formula :
C17H27BO2
Molecular Weight :
274.21

IUPAC Name:2-(4-(tert-butyl)-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-(tert-butyl)-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(tert-butyl)-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(4-(tert-butyl)-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC17H27BO2
Molecular Weight274.21
SMILESCC1=CC(C(C)(C)C)=CC=C1B1OC(C)(C)C(C)(C)O1
InChI KeySZJWXXGTSZCNMN-UHFFFAOYSA-N
Synonym1,3,2-Dioxaborolane, 2-[4-(1,1-dimethylethyl)-2-methylphenyl]-4,4,5,5-tetramethyl-;2-(4-(tert-butyl)-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS No.2243254-46-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACOOUR636 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACWALY706 route compound structure diagram
    ACWALY706854637-01-7 In Stock
  4. Then
  5. ACOOUR636 route product structure diagram
    ACOOUR6362243254-46-6
Inquiry

2. ACOOUR636 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOOUR636 route product structure diagram
    ACOOUR6362243254-46-6
Inquiry

Comments (0)